Page last updated: 2024-08-16

rizatriptan and Recrudescence

rizatriptan has been researched along with Recrudescence in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (21.43)	18.2507
2000's	10 (71.43)	29.6817
2010's	1 (7.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egan, CG; Mogavero, S; Savi, L	1
Lines, CR; McCarroll, KA; Visser, WH	1
Cady, R; Klipfel, M; Lewis, D; McCarroll, K; Nett, R; Peng, Y; Strohmaier, K; Visser, WH; Winner, P	1
Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA	1
Block, G; Cutler, N; Gross, M; Jiang, K; Reines, S; Smith, B; Teall, J; Tuchman, M; Willoughby, E	1
Deleu, D; Hanssens, Y	1
Allen, C; Bomhof, M; Legg, N; Patel, K; Paz, J; Vandormael, K	1
Logemann, CD; Rankin, LM	1
Allen, C; Diener, HC; Pascual, J; Patel, K; Vega, P; Vrijens, F	1
Saper, JR	1
Potrebic, S; Raskin, NH	1
Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V	1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI	1
Barbosa, JS; Krymchantowski, AV	1

Reviews

6 review(s) available for rizatriptan and Recrudescence

Article	Year
Rizatriptan: pharmacological differences from sumatriptan and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Administration, Oral; Humans; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2001
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents	1999
Newer intranasal migraine medications. American family physician, 2000, Jan-01, Volume: 61, Issue:1 Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2000
The use of rizatriptan in the treatment of acute, multiple migraine attacks. Neurology, 2000, Volume: 55, Issue:9 Suppl 2 Topics: Acute Disease; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines	2000
New abortive agents for the treatment of migraine. Advances in internal medicine, 2001, Volume: 46 Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294 Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines	2001

Trials

7 trial(s) available for rizatriptan and Recrudescence

Article	Year
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine. Drug design, development and therapy, 2014, Volume: 8 Topics: Adult; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2014
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache, 2004, Volume: 44, Issue:9 Topics: Acute Disease; Adolescent; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2004
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Headache, 1998, Volume: 38, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines	1998
Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. European neurology, 1999, Volume: 42, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Piperidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines	1999
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:5 Topics: Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Oxazolidinones; Quality of Life; Recurrence; Retreatment; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines	2000
Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes. Headache, 2001, Volume: 41, Issue:3 Topics: Adult; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2001
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines	2002

Other Studies

1 other study(ies) available for rizatriptan and Recrudescence

Article	Year
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:5 Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2005

Article

Year

Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.

Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:5

Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2005